back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-02-10 17:22 Tx date 2021-01-07 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Weir-Jones Engineering Consultants Ltd. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$100,000
+2,000,000 vol $0.05 each |
4,077,451 | |
| Filed 2021-02-10 17:16 Tx date 2014-09-05 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Weir-Jones Engineering Consultants Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,077,451 | ||
| Filed 2020-04-29 14:03 Tx date 2020-04-27 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+1,200,000 vol |
2,077,452 | |
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-7,897,068 vol |
877,452 | |
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-1,701,000 vol |
189,000 | |
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-6,210,000 vol |
690,000 | |
| Filed 2017-02-17 Tx date 2017-02-17 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,250
+150,000 vol $0.035 each |
8,774,520 | |
| Filed 2017-01-04 Tx date 2017-01-03 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+4,500,000 vol |
6,900,000 | |
| Filed 2016-05-13 Tx date 2016-05-12 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+890,000 vol |
1,890,000 | |
| Filed 2016-05-13 Tx date 2016-05-12 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+890,000 vol |
8,624,520 | |
| Filed 2016-01-05 Tx date 2015-12-31 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,700
+54,000 vol $0.05 each |
||
| Filed 2016-01-05 Tx date 2015-12-31 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,040
+24,000 vol $0.085 each |
7,704,520 | |
| Filed 2016-01-05 Tx date 2015-12-31 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,319
+30,000 vol $0.0773 each |
7,734,520 | |
| Filed 2016-01-04 Tx date 2015-12-31 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,700
+54,000 vol $0.05 each |
7,734,520 | |
| Filed 2015-11-20 Tx date 2015-11-19 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,000,000 vol |
2,400,000 | |
| Filed 2015-10-02 Tx date 2014-09-29 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Elizabeth Weir-Jones (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+1,000,000 vol |
||
| Filed 2015-10-02 Tx date 2014-09-29 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Elizabeth Weir-Jones (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+1,000,000 vol |
||
| Filed 2015-10-02 Tx date 2014-09-05 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Elizabeth Weir-Jones (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-02 Tx date 2015-02-11 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$132,626
+2,652,520 vol $0.05 each |
7,680,520 | |
| Filed 2015-10-02 Tx date 2014-09-29 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Elizabeth Weir-Jones (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$50,000
+1,000,000 vol $0.05 each |
||
| Filed 2015-10-02 Tx date 2014-09-29 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Elizabeth Weir-Jones (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$50,000
+1,000,000 vol $0.05 each |
||
| Filed 2015-10-02 Tx date 2014-09-05 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Elizabeth Weir-Jones (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-02 Tx date 2014-09-05 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Elizabeth Weir-Jones (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-02 Tx date 2014-09-05 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Elizabeth Weir-Jones (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-22 Tx date 2014-09-05 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-22 Tx date 2015-05-20 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
400,000 |